Cargando…

Primary biliary cholangitis associated with SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Bartoli, Alessandra, Gitto, Stefano, Sighinolfi, Pamela, Cursaro, Carmela, Andreone, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892314/ https://www.ncbi.nlm.nih.gov/pubmed/33610679 http://dx.doi.org/10.1016/j.jhep.2021.02.006

Ejemplares similares

Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
por: Bartoli, Alessandra, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies
por: Bartoli, Alessandra, et al.
Publicado: (2022)

Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series
por: Bernasconi, Elisa, et al.
Publicado: (2023)

Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Clinical and serological prognostic markers in primary biliary cholangitis
por: Wilhelmi, Markus
Publicado: (2021)

Autoantibodies to speckled protein family in primary biliary cholangitis
por: Granito, Alessandro, et al.
Publicado: (2021)

Treatments for HBV: A Glimpse into the Future
por: Bartoli, Alessandra, et al.
Publicado: (2021)

Forms of cholangitis to be considered after SARS-CoV-2 infection
por: Cho, Ju-Yeon, et al.
Publicado: (2022)

Ductular reaction is a prognostic factor in primary biliary cholangitis
por: Tan, Youwen, et al.
Publicado: (2023)

Virological Treatment Monitoring for Chronic Hepatitis B
por: Loggi, Elisabetta, et al.
Publicado: (2022)

Timing of biliary decompression for acute cholangitis
por: Yang, Jian, et al.
Publicado: (2023)

Reply to: “Ductular reaction is a prognostic factor in primary biliary cholangitis”
por: Carpino, Guido, et al.
Publicado: (2023)

Comment on “Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis”
por: Cristoferi, Laura, et al.
Publicado: (2020)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Proactive screening approach for SARS-CoV-2 among healthcare workers
por: Oster, Yonatan, et al.
Publicado: (2021)

Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis
por: Dyson, Jessica Katharine, et al.
Publicado: (2020)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Pathophysiology of SARS-CoV-2 associated ischemic stroke
por: Finsterer, Josef, et al.
Publicado: (2022)

Rapid antigen test for SARS-CoV-2 and primary health care
por: Fernández-Villa, T., et al.
Publicado: (2021)

Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
por: Yacoub, Haythem, et al.
Publicado: (2023)

Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
por: Molinaro, Antonio, et al.
Publicado: (2017)

SECONDARY SCLEROSING CHOLANGITIS WITH BILIARY CAST DUE TO SARS-COV-2 INFECTION
por: Kagihara, Jaclyn E., et al.
Publicado: (2022)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_clt5dnaemfiuhjdak95smccdrq